US Pharma Lab LLC
US Pharma Lab LLC, headquartered in Indiana, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality pharmaceutical products. Founded in 2010, the company has established a strong presence across major operational regions in the United States, focusing on innovative solutions that meet the evolving needs of healthcare providers and patients. With a commitment to excellence, US Pharma Lab offers a diverse range of core products, including generic medications and custom formulations. Their unique approach combines advanced technology with rigorous quality control, ensuring that each product meets the highest standards of safety and efficacy. Recognised for their dedication to research and development, US Pharma Lab has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical landscape.
DitchCarbon Score
How does US Pharma Lab LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
US Pharma Lab LLC's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
US Pharma Lab LLC's reported carbon emissions
US Pharma Lab LLC, headquartered in Indiana, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or commitments to climate initiatives. This lack of publicly available information suggests that US Pharma Lab LLC may still be in the early stages of developing a comprehensive climate strategy or may not have formalised their climate commitments within the industry context. As the pharmaceutical sector increasingly prioritises sustainability, it will be essential for US Pharma Lab LLC to establish clear emissions reduction goals and engage in climate action to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
US Pharma Lab LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
